BIOCON BIOLOGICS UK LIMITED BRANCH OFFICE

Business Description

BIOCON BIOLOGICS UK LIMITED BRANCH OFFICE is registered as a business entity on 26 April 2019 (5.5 years ago) structured as a Foreign Company Registered In Singapore (Foreign Company) with 3 officer(s) in-charge. The business jurisdiction is overseen by the Accounting and Corporate Regulatory Authority (ACRA), a government agency from Singapore with the given Business Registration Number / Unique Entity Number (UEN) T19FC0051C. The business official address is located at 70 Shenton Way #07-15, Eon Shenton, Singapore 79118 with main trading activity as Research And Development Of Various Biosimilar Insulin, Monocional Antibodies in the primary industry of 72106: Research And Experimental Development On Medical Science using Singapore Dollars - SGD as its default trading currency. The business legal name has undergone change(s) and is previously known as BIOCON BIOLOGICS LIMITED BRANCH OFFICE. The business annual account filing date falls on 26 April and is no longer operational with the status of 'na'.

In the past 365 days, BIOCON BIOLOGICS UK LIMITED BRANCH OFFICE has received a total of Login to view reported payment review(s). 0 were rated Good and Login to view were rated Poor. Therefore no payment reviews were made recently. The aggregated good payment amount is equivalent to USD 0, and aggregated poor payment amount is equivalent to USD Login to view. Its current payment rating of "A" suggest a healthy payment culture where settlement with stakeholders is always prioritised. Since the business is registered as a foreign company, it is the offshore branch of a parent orgnisation and more research should to be done to understand its local presence. The lack of an appointed auditor indicates that the business is small sized as it did not meet the regulatory requirements of revenue or assets exceeding SGD 10 million, or has more than 50 employees in the previous two fiscal years.

BIOCON BIOLOGICS UK LIMITED BRANCH OFFICE is not yet a Prompt Payment Initiative Signatory.

Last updated on 30 April 2023